SubHero Banner
Text

January 2022

Core topics in this month’s edition include:

  • Spikevax (COVID-19 vaccine, mRNA) – vaccine approval
  • Bamlanivimab/etesevimab and REGN-COV (casirivimab/imdevimab) – emergency use authorization revision
  • Moderna and Pfizer/BionNTech COVID-19 Vaccines – emergency use authorization expansion

Download PDF

Text